The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Drs. Neumeister and Manji Reply

To the Editor: We read with interest the letter by Dr. Mackin and Mr. Gallagher in which they suggest interpreting the interactive effects of BDNF and serotonin in major depressive disorder in the context of HPA axis function. Preclinical studies (1) have suggested major functional interactions between knockout mice with genetically induced alterations in serotonin (5-HT) transporters and heterozygous BDNF knockout mice and have also shown that this leads to enhanced stress responses with altered HPA axis function. Notably, a decrease in BDNF concentrations does not appear sufficient to lower extracellular 5-HT; similarly, constitutional changes in extracellular 5-HT because of differences in 5-HT reuptake by 5-HT transporters do not affect BDNF protein levels. This adds to the importance of identifying additional parameters that may contribute to the interactive effects of 5-HT and BDNF in major depressive disorder. There is a wide range of evidence supporting the idea that glucocorticoids play a key role in acute and chronic stress responses. For example, stress and glucocorticoids impair hippocampal neurogenesis; furthermore, in addition to directly causing neuronal atrophy, stress and glucocorticoids also impair cellular resilience that together may lead to the well-established morphological alterations in major depressive disorder. Notably, BDNF and other neurotrophic factors are believed to counteract these effects (2). It has been previously demonstrated that in addition to glucocorticoids, BDNF is involved in the early response to acute stress (3). In our study, tryptophan depletion was used as a model to study the effects of acute stress in the context of reduced 5-HT function in major depressive disorder and healthy comparison subjects. Additional work is clearly necessary to delineate the causal relationships between altered 5-HT function, BDNF, and HPA axis function and the pathogenesis of major depressive disorder. Dysregulation of these cascades may be a key mechanism by which stress induces impairments of cellular plasticity. This highlights the interactive effects of different neurobiological systems in the pathogenesis of major depressive disorder, and all three of the referenced major neurobiological systems appear to be involved.

References

1. Ren-Patterson RF, Cochran LW, Holmes A, Sherrill S, Huang SJ, Tolliver T, Lesch KP, Lu B, Murphy DL: Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J Neurosci Res 2005; 79:756–771Crossref, MedlineGoogle Scholar

2. Manji HK, Quiroz JA, Sporn J, Payne JL, Denicoff K, Gray NA, Zarate CA Jr, Charney DS: Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 2003; 53:707–742Crossref, MedlineGoogle Scholar

3. Marmigere F, Givalois L, Rage F, Arancibia S, Tapia-Arancibia L: Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats. Hippocampus 2003; 13:646–655Crossref, MedlineGoogle Scholar